C. difficile 위험도


Gram-positive infection 1-2 g IV #2-3

Gram-negative infection 3-4 g IV #2-3

(max 6 g/d, if severe)

Safety and efficacy in pediatric patients have not been established

Contraindicated in premature infants and neonates

No dose adjustment

Loading dose and interval are determined by the extent of renal damage

General Information

  • Urinary tract infectious disease

  • Cholangitis

  • Intrauterine infections

  • Cholangitis

  • Skin and soft tissue infection

  • Osteoarthritis

  • Surgical infection prevention and potential infection treatment

Monitor susceptibility to prevent occurrence of resistant bacteria.

Monitor status of patients whether shock occurs.

Perform skin reaction test prior to treatment.

  • Headache

  • Dizziness

  • Nausea

  • Vomiting

  • Loss of appetite

  • Abdominal pain

  • Diarrhea

  • Hypersensitivity reaction

  • Anaphylaxis (rare)

Increased nephrotoxicity with:

  • Aminoglycoside

  • PolymyxinB

  • Colistin

  • High dose diuretics

May affect coagulation of blood with:

  • High dose oral anticoagulants

Antimicrobial class: 1st Genration Cephalosporin

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.